Daniel Magoon
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
Papers in
- Hematology 15
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 3
- Oncology 6
- Chemokine receptors and signaling 6
- Co-authors
- Patrick Andrew Brown (19 shared papers)Edward Allan R. Sison (11 shared papers)Peter Valent (1 shared paper)Scott Lowe (1 shared paper)Agustin Chicas (1 shared paper)Mark Wunderlich (1 shared paper)Eric Wang (1 shared paper)Scott C. Kogan (1 shared paper)
- Journals
- Blood (10 papers)Oncotarget (3 papers)Pediatric Blood & Cancer (2 papers)Molecular Cancer Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Daniel Magoon
20 papers receiving 2.0k citations
Daniel Magoon's Hit Papers
Peers
Comparison fields: 5 of 58
- Hematology 913
- Molecular Biology 1.6k
- Oncology 364
- Genetics 117
- Immunology 192
Countries citing papers authored by Daniel Magoon
This map shows the geographic impact of Daniel Magoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Magoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Magoon more than expected).
Fields of papers citing papers by Daniel Magoon
This network shows the impact of papers produced by Daniel Magoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Magoon. The network helps show where Daniel Magoon may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Magoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1581 |
| 2 | 2015 | 109 | |
| 3 | 2013 | 92 | |
| 4 | 2017 | 65 | |
| 5 | 2016 | 63 | |
| 6 | 2014 | 54 | |
| 7 | 2015 | 34 | |
| 8 | 2013 | 27 | |
| 9 | 2012 | 7 | |
| 10 | 2013 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2013 | 5 | |
| 13 | 2018 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2011 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2015 | 1 |
About Daniel Magoon
Daniel Magoon is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Immunology, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (6 papers), Chemokine receptors and signaling (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Hematology (913 citations), Molecular Biology (1.6k citations), Oncology (364 citations), Genetics (117 citations) and Immunology (192 citations). Daniel Magoon has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Patrick Andrew Brown, Edward Allan R. Sison, Peter Valent, Scott Lowe, Agustin Chicas, Mark Wunderlich, Eric Wang, Scott C. Kogan, Christopher R. Vakoc and Johannes A. Zuber. Their work appears in journals such as Blood, Oncotarget, Pediatric Blood & Cancer, Molecular Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.